These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 1658652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.
    Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA.
    N Engl J Med; 1991 Apr 11; 324(15):1005-11. PubMed ID: 1848679
    [Abstract] [Full Text] [Related]

  • 3. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.
    Winston DJ, Ho WG, Bartoni K, Du Mond C, Ebeling DF, Buhles WC, Champlin RE.
    Ann Intern Med; 1993 Feb 01; 118(3):179-84. PubMed ID: 8380243
    [Abstract] [Full Text] [Related]

  • 4. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant.
    Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD.
    Ann Intern Med; 1993 Feb 01; 118(3):173-8. PubMed ID: 8380242
    [Abstract] [Full Text] [Related]

  • 5. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ, Miller W, Kandaswamy C, DeFor TE, MacMillan ML, Van Burik JA, Weisdorf DJ.
    Bone Marrow Transplant; 2002 Dec 01; 30(12):945-51. PubMed ID: 12476289
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.
    Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM.
    N Engl J Med; 1992 Apr 30; 326(18):1182-6. PubMed ID: 1313549
    [Abstract] [Full Text] [Related]

  • 8. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C, Culbert S, Gardner M, Whimbey E, Tarrand J, Chan KW.
    Bone Marrow Transplant; 1996 Apr 30; 17(4):589-93. PubMed ID: 8722360
    [Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
    Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA.
    Blood; 1996 Nov 15; 88(10):4063-71. PubMed ID: 8916975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
    Ippoliti C, Morgan A, Warkentin D, van Besien K, Mehra R, Khouri I, Giralt S, Gajewski J, Champlin R, Andersson B, Przepiorka D.
    Bone Marrow Transplant; 1997 Sep 15; 20(6):491-5. PubMed ID: 9313883
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.